About Us

Intellihealth is transforming how specialized treatment for chronic conditions can be administered by combining the best in medical science with advanced digital technologies. Our primary objective is obesity, an epidemic that is one of the most urgent health issues of our time and a key risk factor leading to many serious illnesses, including cardiovascular disease and diabetes.

About Us

Intellihealth is transforming how specialized treatment for chronic conditions can be administered by combining the best in medical science with advanced digital technologies. Our primary objective is obesity, an epidemic that is one of the most urgent health issues of our time and a key risk factor leading to many serious illnesses, including cardiovascular disease and diabetes.
Over 40% of Americans have obesity and that number is projected to grow to 50% within the next decade. Despite this, less than 2% of those 130 million people currently receive medical obesity treatment according to guidelines. This is due to a severe shortage of specialists and is compounded by geographic and socioeconomic factors. Also, most people are not aware that obesity is a disease, which it was declared by the American Medical Association in 2013. This misconception worsens the already stigmatized perception of obesity as being a result of personal failure or laziness. So, even if people are aware of treatment options, access is highly limited. And the reality is that the common refrain of, “eat less, exercise more,” frankly doesn’t work for the majority of people with obesity because there are complex systems within the body that have evolved to actually prevent weight loss.
Having pioneered the study and treatment of obesity for over 30 years, Intellihealth’s Chief Medical Officer and co-founder, Dr. Louis Aronne, is someone with a deep understanding of these complex systems. One of the preeminent authorities on obesity, Dr. Aronne, is a founding member of the American Board of Obesity Medicine (ABOM) and his clinic and research center, the Comprehensive Weight Control Center (CWCC) has refined a benchmark treatment approach that is among the best in the medical world. However, as effective as this approach is, the inherent constraints of a physical clinic limit access for most people.
Enter: Digital technology. In 2017, Dr. Aronne, along with his first clinical fellow, Dr. Katherine Saunders, and her husband Sloan Saunders, an entrepreneur, founded Intellihealth. Their aim was to develop a software solution that could effectively scale this specialized treatment beyond the clinic to meet the magnitude of the epidemic. For the previous decade, Dr. Aronne had been working to digitize his approach and data in the form of an innovative platform called BMIQ, which ultimately would serve as the foundation for Intellihealth. To build on the success of BMIQ, they assembled a world class team of multidisciplinary medical professionals, expert software engineers and healthcare industry veterans to create a platform that could easily integrate into any practice and enable any provider to administer specialized obesity treatment to patients, both remotely and in-person. The result was Evolve, which launched in 2020 and is already being used at several major hospital systems.

Evolve represents a major milestone in Intellihealth’s central mission: Redefine the perception of obesity as a medical disease and expand access to care with a scalable treatment solution that helps millions of people live longer, healthier lives.

Evolve represents a major milestone in Intellihealth’s central mission: Redefine the perception of obesity as a medical disease

and expand access to care with a scalable treatment solution that helps millions of people live longer, healthier lives.

Over 40% of Americans have obesity and that number is projected to grow to 50% within the next decade. Despite this,
less than 2% of those 130 million people currently receive medical obesity treatment according to guidelines. This is due
to a severe shortage of specialists and is compounded by geographic and socioeconomic factors. Also, most people are not
aware that obesity is a disease, which it was declared by the American Medical Association in 2013. This misconception worsens
the already stigmatized perception of obesity as being a result of personal failure or laziness. So, even if people are aware of treatment options, access is highly limited. And the reality is that the common refrain of, “eat less, exercise more,” frankly doesn’t work for the majority of people with obesity because there are complex systems within the body that have evolved to actually prevent weight loss.
Having pioneered the study and treatment of obesity for over 30 years, Intellihealth’s Chief Medical Officer and co-founder, Dr. Louis Aronne, is someone with a deep understanding of these complex systems. One of the preeminent authorities on obesity, Dr. Aronne, is a founding member of the American Board of Obesity Medicine (ABOM) and his clinic and research center, the Comprehensive Weight Control Center (CWCC) has refined a benchmark treatment approach that is among the best in the medical world. However, as effective as this approach is, the inherent constraints of a physical clinic limit access for most people.
Enter: Digital technology. In 2017, Dr. Aronne, along with his first clinical fellow, Dr. Katherine Saunders, and her husband Sloan Saunders, an entrepreneur, founded Intellihealth. Their aim was to develop a software solution that could effectively scale this specialized treatment beyond the clinic to meet the magnitude of the epidemic. For the previous decade, Dr. Aronne had been working to digitize his approach and data in the form of an innovative platform called BMIQ, which ultimately would serve as the foundation for Intellihealth. To build on the success of BMIQ, they assembled a world class team of multidisciplinary medical professionals, expert software engineers and healthcare industry veterans to create a platform that could easily integrate into any practice and enable any provider to administer specialized obesity treatment to patients, both remotely and in-person. The result was Evolve, which launched in 2020 and is already being used at several major hospital systems.

Evolve represents a major milestone in Intellihealth’s central mission: Redefine the perception of obesity as a medical disease and expand access to care with a scalable treatment solution that helps millions of people live longer, healthier lives.

Evolve represents a major milestone in Intellihealth’s central mission: Redefine the perception of obesity as a medical disease

and expand access to care with a scalable treatment solution that helps millions of people live longer, healthier lives.

Transforming obesity
treatment to transform lives

Contact Us

Thank you for getting in touch!​
One of our colleagues will get back in touch with you soon!